Skip to content
Clinical Trials – home
CyprusBack to Cyprus

Clinical trials in Agios Dometios

7 clinical trials in Agios Dometios, Cyprus. Every trial is listed in the EU Clinical Trials Register and updated daily.

Agios Dometios at a glance
7
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

7 trials in Agios Dometios

Open in trial search
Countries:CyprusCyprus
  • Participants:18–64 years · 65+ years
  • Substances:Vutrisiran
  • Sponsor:Alnylam Pharmaceuticals Inc.
Countries:CyprusCyprus
  • Participants:18–64 years · 65+ years
  • Substances:Eplontersen
  • Sponsor:Ionis Pharmaceuticals Inc.

Ocular myasthenia

Not recruiting
Registered drug
Countries:CyprusCyprus
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx
Countries:CyprusCyprus
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

Myasthenia gravis

Not recruiting
Registered drug
Countries:CyprusCyprus
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx
Countries:CyprusCyprus
  • Participants:18–64 years · 65+ years
  • Substances:Patisiran
  • Sponsor:Alnylam Pharmaceuticals Inc.
Countries:CyprusCyprus
  • Participants:18–64 years · 65+ years
  • Substances:Azathioprine
  • Sponsor:Argenx

Other cities in Cyprus

The busiest research cities in the country

All 4 cities in Cyprus

Clinical research in Agios Dometios

What the registry says about research in the country

01 Myasthenia Research

Innovative clinical studies focusing on Ocular Myasthenia Gravis and Generalized Myasthenia Gravis, evaluating new therapeutic approaches using efgartigimod in different formulations. These trials aim to improve treatment options for patients with varying presentations of the condition.

  • Ocular Myasthenia Gravis Treatment
  • Seronegative MG Therapies
  • Subcutaneous Treatment Development

Research emphasizes both efficacy and safety profiles in different patient populations.

02 Inflammatory Myopathy Studies

Comprehensive research into Idiopathic Inflammatory Myopathy, investigating both short-term and long-term treatment outcomes. These trials evaluate novel therapeutic approaches while maintaining established immunomodulatory therapies.

  • Long-term Safety Assessment
  • Treatment Efficacy Evaluation
  • Combined Therapy Approaches

Studies focus on developing sustainable treatment options for chronic inflammatory conditions.

03 Amyloidosis Research

Groundbreaking studies on Hereditary Transthyretin Amyloidosis, including investigations of new compounds targeting neurologic impairment. The research encompasses both established and innovative therapeutic approaches.

  • Polyneuropathy Treatment
  • Novel Therapeutic Compounds
  • Extended Treatment Protocols

These trials aim to advance treatment options for patients with hereditary amyloid disorders.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.